 |
PDBsum entry 4mnv
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
4mnv
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Peptide ligands stabilized by small molecules.
|
 |
|
Authors
|
 |
S.Chen,
D.Bertoldo,
A.Angelini,
F.Pojer,
C.Heinis.
|
 |
|
Ref.
|
 |
Angew Chem Int Ed Engl, 2014,
53,
1602-1606.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Bicyclic peptides generated through directed evolution by using phage display
offer an attractive ligand format for the development of therapeutics. Being
nearly 100-fold smaller than antibodies, they promise advantages such as access
to chemical synthesis, efficient diffusion into tissues, and needle-free
application. However, unlike antibodies, they do not have a folded structure in
solution and thus bind less well. We developed bicyclic peptides with
hydrophilic chemical structures at their center to promote noncovalent
intramolecular interactions, thereby stabilizing the peptide conformation. The
sequences of the peptides isolated by phage display from large combinatorial
libraries were strongly influenced by the type of small molecule used in the
screen, thus suggesting that the peptides fold around the small molecules. X-ray
structure analysis revealed that the small molecules indeed formed hydrogen
bonds with the peptides. These noncovalent interactions stabilize the
peptide-protein complexes and contribute to the high binding affinity.
|
 |
|
|
|
|
 |